182 related articles for article (PubMed ID: 37784150)
1. scFv biofunctionalized nanoparticles to effective and safe targeting of CEA-expressing colorectal cancer cells.
Silveira MJ; Martins C; Cruz T; Castro F; Amorim-Costa Â; Chester K; Oliveira MJ; Sarmento B
J Nanobiotechnology; 2023 Oct; 21(1):357. PubMed ID: 37784150
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of chemosensitivity in 5-fluorouracil-resistant colon cancer cells with carcinoembryonic antigen-specific RNA aptamer.
Lee JH; Lee SW
Mol Biol Rep; 2019 Aug; 46(4):3835-3842. PubMed ID: 31028570
[TBL] [Abstract][Full Text] [Related]
3. Carcinoembryonic antigen-targeted nanoparticles potentiate the delivery of anticancer drugs to colorectal cancer cells.
Pereira I; Sousa F; Kennedy P; Sarmento B
Int J Pharm; 2018 Oct; 549(1-2):397-403. PubMed ID: 30110619
[TBL] [Abstract][Full Text] [Related]
4. Sulfonamide-Functionalized Polymeric Nanoparticles for Enhanced In Vivo Colorectal Cancer Therapy.
Guimarães PPG; Viana CTR; Pereira L; Gontijo SML; Campos PP; Andrade SP; Santos RAS; Sinisterra RD
Curr Drug Deliv; 2022; 19(6):676-685. PubMed ID: 34325632
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen expression level as a predictive factor for response to 5-fluorouracil in colorectal cancer.
Eftekhar E; Naghibalhossaini F
Mol Biol Rep; 2014 Jan; 41(1):459-66. PubMed ID: 24293105
[TBL] [Abstract][Full Text] [Related]
6. Impact of CEA-targeting Nanoparticles for Drug Delivery in Colorectal Cancer.
Sousa AR; Oliveira MJ; Sarmento B
J Pharmacol Exp Ther; 2019 Sep; 370(3):657-670. PubMed ID: 30670480
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin.
Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S
J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693
[TBL] [Abstract][Full Text] [Related]
8. EpCAM aptamer activated 5-FU-loaded PLGA nanoparticles in CRC treatment; in vitro and in vivo study.
Yavari B; Athari SS; Omidi Y; Jalali A; Najafi R
J Drug Target; 2023 Mar; 31(3):296-309. PubMed ID: 36398476
[TBL] [Abstract][Full Text] [Related]
9. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the tumor-targeting specific imaging and killing effect of a CEA-targeting nanoparticle in colorectal cancer.
Feng Q; Wang SA; Ning B; Xie J; Ding J; Liu S; Ai S; Li F; Wang X; Guan W
Biochem Biophys Res Commun; 2024 Jul; 719():150084. PubMed ID: 38733742
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
[TBL] [Abstract][Full Text] [Related]
12. CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.
Oberst MD; Fuhrmann S; Mulgrew K; Amann M; Cheng L; Lutterbuese P; Richman L; Coats S; Baeuerle PA; Hammond SA
MAbs; 2014; 6(6):1571-84. PubMed ID: 25484061
[TBL] [Abstract][Full Text] [Related]
13. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of CEA and MHC class I in colorectal cancer cell lines exposed to chemotherapy drugs.
Ohtsukasa S; Okabe S; Yamashita H; Iwai T; Sugihara K
J Cancer Res Clin Oncol; 2003 Dec; 129(12):719-26. PubMed ID: 14564514
[TBL] [Abstract][Full Text] [Related]
15. The CEA-/lo colorectal cancer cell population harbors cancer stem cells and metastatic cells.
Yan C; Hu Y; Zhang B; Mu L; Huang K; Zhao H; Ma C; Li X; Tao D; Gong J; Qin J
Oncotarget; 2016 Dec; 7(49):80700-80715. PubMed ID: 27813496
[TBL] [Abstract][Full Text] [Related]
16. Generation and
Plüss L; Peissert F; Elsayed A; Rotta G; Römer J; Dakhel Plaza S; Villa A; Puca E; De Luca R; Oxenius A; Neri D
MAbs; 2023; 15(1):2217964. PubMed ID: 37243574
[TBL] [Abstract][Full Text] [Related]
17. High-Precision Quantitative Analysis Reveals Carcinoembryonic Protein Expression Differs Among Colorectal Cancer Primary Foci and Metastases to Different Sites.
Zhu Y; Zhang Q; Wei C; Hu Y; Gong H; Liu Y; Lai H; Feng Y; Lin Y
Technol Cancer Res Treat; 2021; 20():15330338211037175. PubMed ID: 34342245
[TBL] [Abstract][Full Text] [Related]
18. Screening and characterization of the scFv for chimeric antigen receptor T cells targeting CEA-positive carcinoma.
Zhang C; Wang L; Zhang Q; Shen J; Huang X; Wang M; Huang Y; Chen J; Xu Y; Zhao W; Qi Y; Li Y; Ou Y; Yang Z; Qian C
Front Immunol; 2023; 14():1182409. PubMed ID: 37304295
[TBL] [Abstract][Full Text] [Related]
19. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
[No Abstract] [Full Text] [Related]
20. The role of tissue and serum carcinoembryonic antigen in stages I to III of colorectal cancer-A retrospective cohort study.
Tong G; Xu W; Zhang G; Liu J; Zheng Z; Chen Y; Niu P; Xu X
Cancer Med; 2018 Nov; 7(11):5327-5338. PubMed ID: 30302946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
